Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab Administration.

doi:10.1093/infdis/jiaf530

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab Administration.

The Journal of infectious diseases - 18 Feb 2026

Iglesias-Caballero María, Mas Vicente, Campoy Albert, Calvo Cristina, García María Luz, Alcolea Sonia, Moreno-Parrado Laura, Reina Jordi, Navascués Ana, Antón Andrés, Davina-Nunez Carlos, Perez-Castro Sonia, Costa José, Fernández-González Ana, Lepe José Antonio, Gaona Cristina, Pérez Zulema, García-Martínez de Artola Diego, Vázquez-Morón Sonia, Camarero Sara, Cano Olga, Pozo Francisco, Casas Inmaculada

Abstract excerpt

Respiratory Syncytial Virus (RSV) is a leading cause of respiratory infections in infants and older adults. In Spain, surveillance is supported by the SiVIRA system and the RELECOV genomic sequencing network. The 2023-2024 season marked the first nationwide administration of nirsevimab, a monoclonal antibody for preventing severe RSV in infants. This study analyzes the genomic evolution of RSV during this period,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibodies, Viral

Share to Antigens, Viral

Share to Respiratory Syncytial Virus, Human

Share to Respiratory Syncytial Virus Infections

Share to Seasons

Share to Spain

Share to Viral Fusion Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 41103028
DOI: 10.1093/infdis/jiaf530
PMCID: PMC13017623

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab Administration.PMID 41103028Read ↗

Genomic evolution of human respiratory syncytial virus during a decade (2013-2023): bridging the path to monoclonal antibody surveillance.Semantic proximity Read ↗

Respiratory Syncytial virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab ProphylaxisSemantic proximity Read ↗

Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France.Semantic proximity Read ↗

Genomic Evolution and Surveillance of Respiratory Syncytial Virus during the 2023-2024 Season.Semantic proximity Read ↗

Prevalence and genetic diversity of respiratory syncytial viruses circulating in Bulgaria, 2023-2025.Semantic proximity Read ↗

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus.Semantic proximity Read ↗

Subtype-specific differences in susceptibility to monoclonal antibodies and vaccines among contemporary RSV-A and RSV-B isolatesSemantic proximity Read ↗

The molecular epidemiology of respiratory syncytial virus in Ontario, Canada from 2022–2024 using a custom whole genome sequencing assay and analytics packageSemantic proximity Read ↗

Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017-2018 INFORM-RSV Study.Semantic proximity Read ↗

Whole-Genome Sequencing and Genetic Diversity of Human Respiratory Syncytial Virus in Patients with Influenza-like Illness in Sicily (Italy) from 2017 to 2023.Semantic proximity Read ↗

Functional implications of respiratory syncytial virus F sequence variability: a comparative analysis using contemporary RSV isolatesSemantic proximity Read ↗

A multi-center study to determine genetic variations in the fusion gene of respiratory syncytial virus (RSV) from children <2 years of age in the U.S.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.